Click for best price
AntiHIV Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Anti-HIV Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-HIV Drugs. This report contains market size and forecasts of Anti-HIV Drugs in global, including the following market information:
Global Anti-HIV Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Anti-HIV Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Multi-class Combination Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-HIV Drugs include Gilead Sciences, ViiV Healthcare, Merck & Co., AbbVie, Roche Holding AG, Teva Pharmaceuticals, Bristol Myers Squibb, Pfizer and Shionogi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-HIV Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-HIV Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Anti-HIV Drugs Market Segment Percentages, by Type, 2022 (%)
Multi-class Combination Drugs
Nucleoside Reverse Transcriptase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
HIV Integrase Strand Transfer Inhibitors
Global Anti-HIV Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Anti-HIV Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
Global Anti-HIV Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Anti-HIV Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-HIV Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-HIV Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
ViiV Healthcare
Merck & Co.
AbbVie
Roche Holding AG
Teva Pharmaceuticals
Bristol Myers Squibb
Pfizer
Shionogi
Cipla
Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-HIV Drugs, market overview.
Chapter 2: Global Anti-HIV Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-HIV Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-HIV Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-HIV Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-HIV Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-HIV Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-HIV Drugs Overall Market Size
2.1 Global Anti-HIV Drugs Market Size: 2022 VS 2032
2.2 Global Anti-HIV Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-HIV Drugs Players in Global Market
3.2 Top Global Anti-HIV Drugs Companies Ranked by Revenue
3.3 Global Anti-HIV Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-HIV Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-HIV Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-HIV Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-HIV Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-HIV Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-HIV Drugs Market Size Markets, 2022 & 2032
4.1.2 Multi-class Combination Drugs
4.1.3 Nucleoside Reverse Transcriptase Inhibitors
4.1.4 Non-nucleoside Reverse Transcriptase Inhibitors
4.1.5 HIV Integrase Strand Transfer Inhibitors
4.2 By Type - Global Anti-HIV Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-HIV Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-HIV Drugs Revenue, 2024-2032
4.2.3 By Type - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-HIV Drugs Market Size, 2022 & 2032
5.1.2 Hospitals and Clinics
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Anti-HIV Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-HIV Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-HIV Drugs Revenue, 2024-2032
5.2.3 By Application - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Anti-HIV Drugs Market Size, 2022 & 2032
6.2 By Region - Global Anti-HIV Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-HIV Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-HIV Drugs Revenue, 2024-2032
6.2.3 By Region - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Anti-HIV Drugs Revenue, 2018-2032
6.3.2 US Anti-HIV Drugs Market Size, 2018-2032
6.3.3 Canada Anti-HIV Drugs Market Size, 2018-2032
6.3.4 Mexico Anti-HIV Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Anti-HIV Drugs Revenue, 2018-2032
6.4.2 Germany Anti-HIV Drugs Market Size, 2018-2032
6.4.3 France Anti-HIV Drugs Market Size, 2018-2032
6.4.4 U.K. Anti-HIV Drugs Market Size, 2018-2032
6.4.5 Italy Anti-HIV Drugs Market Size, 2018-2032
6.4.6 Russia Anti-HIV Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Anti-HIV Drugs Market Size, 2018-2032
6.4.8 Benelux Anti-HIV Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Anti-HIV Drugs Revenue, 2018-2032
6.5.2 China Anti-HIV Drugs Market Size, 2018-2032
6.5.3 Japan Anti-HIV Drugs Market Size, 2018-2032
6.5.4 South Korea Anti-HIV Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Anti-HIV Drugs Market Size, 2018-2032
6.5.6 India Anti-HIV Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Anti-HIV Drugs Revenue, 2018-2032
6.6.2 Brazil Anti-HIV Drugs Market Size, 2018-2032
6.6.3 Argentina Anti-HIV Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-HIV Drugs Revenue, 2018-2032
6.7.2 Turkey Anti-HIV Drugs Market Size, 2018-2032
6.7.3 Israel Anti-HIV Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Anti-HIV Drugs Market Size, 2018-2032
6.7.5 UAE Anti-HIV Drugs Market Size, 2018-2032
7 Anti-HIV Drugs Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Anti-HIV Drugs Major Product Offerings
7.1.4 Gilead Sciences Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 ViiV Healthcare
7.2.1 ViiV Healthcare Company Summary
7.2.2 ViiV Healthcare Business Overview
7.2.3 ViiV Healthcare Anti-HIV Drugs Major Product Offerings
7.2.4 ViiV Healthcare Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.2.5 ViiV Healthcare Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Company Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Anti-HIV Drugs Major Product Offerings
7.3.4 Merck & Co. Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 AbbVie
7.4.1 AbbVie Company Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Anti-HIV Drugs Major Product Offerings
7.4.4 AbbVie Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.4.5 AbbVie Key News & Latest Developments
7.5 Roche Holding AG
7.5.1 Roche Holding AG Company Summary
7.5.2 Roche Holding AG Business Overview
7.5.3 Roche Holding AG Anti-HIV Drugs Major Product Offerings
7.5.4 Roche Holding AG Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.5.5 Roche Holding AG Key News & Latest Developments
7.6 Teva Pharmaceuticals
7.6.1 Teva Pharmaceuticals Company Summary
7.6.2 Teva Pharmaceuticals Business Overview
7.6.3 Teva Pharmaceuticals Anti-HIV Drugs Major Product Offerings
7.6.4 Teva Pharmaceuticals Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.6.5 Teva Pharmaceuticals Key News & Latest Developments
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Company Summary
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Anti-HIV Drugs Major Product Offerings
7.7.4 Bristol Myers Squibb Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.7.5 Bristol Myers Squibb Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Anti-HIV Drugs Major Product Offerings
7.8.4 Pfizer Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Shionogi
7.9.1 Shionogi Company Summary
7.9.2 Shionogi Business Overview
7.9.3 Shionogi Anti-HIV Drugs Major Product Offerings
7.9.4 Shionogi Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.9.5 Shionogi Key News & Latest Developments
7.10 Cipla
7.10.1 Cipla Company Summary
7.10.2 Cipla Business Overview
7.10.3 Cipla Anti-HIV Drugs Major Product Offerings
7.10.4 Cipla Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.10.5 Cipla Key News & Latest Developments
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Company Summary
7.11.2 Boehringer Ingelheim Business Overview
7.11.3 Boehringer Ingelheim Anti-HIV Drugs Major Product Offerings
7.11.4 Boehringer Ingelheim Anti-HIV Drugs Revenue in Global Market (2018-2023)
7.11.5 Boehringer Ingelheim Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-HIV Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-HIV Drugs Market Drivers in Global Market
Table 3. Anti-HIV Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-HIV Drugs in Global Market
Table 5. Top Anti-HIV Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-HIV Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-HIV Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-HIV Drugs Product Type
Table 9. List of Global Tier 1 Anti-HIV Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-HIV Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-HIV Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Anti-HIV Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-HIV Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Anti-HIV Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Anti-HIV Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-HIV Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Anti-HIV Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Anti-HIV Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-HIV Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Anti-HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-HIV Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Anti-HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-HIV Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Anti-HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-HIV Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Anti-HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-HIV Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Anti-HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-HIV Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Gilead Sciences Company Summary
Table 31. Gilead Sciences Anti-HIV Drugs Product Offerings
Table 32. Gilead Sciences Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Sciences Key News & Latest Developments
Table 34. ViiV Healthcare Company Summary
Table 35. ViiV Healthcare Anti-HIV Drugs Product Offerings
Table 36. ViiV Healthcare Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. ViiV Healthcare Key News & Latest Developments
Table 38. Merck & Co. Company Summary
Table 39. Merck & Co. Anti-HIV Drugs Product Offerings
Table 40. Merck & Co. Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck & Co. Key News & Latest Developments
Table 42. AbbVie Company Summary
Table 43. AbbVie Anti-HIV Drugs Product Offerings
Table 44. AbbVie Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. AbbVie Key News & Latest Developments
Table 46. Roche Holding AG Company Summary
Table 47. Roche Holding AG Anti-HIV Drugs Product Offerings
Table 48. Roche Holding AG Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Holding AG Key News & Latest Developments
Table 50. Teva Pharmaceuticals Company Summary
Table 51. Teva Pharmaceuticals Anti-HIV Drugs Product Offerings
Table 52. Teva Pharmaceuticals Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Pharmaceuticals Key News & Latest Developments
Table 54. Bristol Myers Squibb Company Summary
Table 55. Bristol Myers Squibb Anti-HIV Drugs Product Offerings
Table 56. Bristol Myers Squibb Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol Myers Squibb Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Anti-HIV Drugs Product Offerings
Table 60. Pfizer Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Shionogi Company Summary
Table 63. Shionogi Anti-HIV Drugs Product Offerings
Table 64. Shionogi Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Shionogi Key News & Latest Developments
Table 66. Cipla Company Summary
Table 67. Cipla Anti-HIV Drugs Product Offerings
Table 68. Cipla Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Cipla Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Anti-HIV Drugs Product Offerings
Table 72. Boehringer Ingelheim Anti-HIV Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Boehringer Ingelheim Key News & Latest Developments
List of Figures
Figure 1. Anti-HIV Drugs Segment by Type in 2022
Figure 2. Anti-HIV Drugs Segment by Application in 2022
Figure 3. Global Anti-HIV Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-HIV Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Anti-HIV Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-HIV Drugs Revenue in 2022
Figure 8. By Type - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Anti-HIV Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Anti-HIV Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 16. US Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 28. China Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Anti-HIV Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Anti-HIV Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Gilead Sciences Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ViiV Healthcare Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck & Co. Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AbbVie Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Holding AG Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Pharmaceuticals Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol Myers Squibb Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Shionogi Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Cipla Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Boehringer Ingelheim Anti-HIV Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
